ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Transcatheter

Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement

Using an approach that minimizes valve depth relative to the membranous septum, the authors reduced the need for permanent pacemaker placement to a reliable and predictable 3% compared to the accepted standard of 10%.

In Global News: Lung Cancer Screening Eligibility, Geriatric Surgery Care Standards, and Studying Venom for Cardiac Protection

Patient Care and General Interest

The American College of Surgeons introduced a new quality improvement program, the Geriatric Surgery Verification Program, which outlines standards for geriatric surgery with the goal of continuously optimizing care for older adults.

Transcatheter Valve-in-Valve Versus Surgical Replacement of Failing Stented Aortic Biological Valves

This retrospective study by Sedeek et al aimed to compare the outcomes of patients undergoing transcatheter aortic valve replacement (TAVR) valve-in-valve (n=90) versus surgical replacement (SAVR) (n=260) of failing stented aortic biological valves in a cohort of 350 patients . They demonstrated that despite the TAVR-in-valve cohort being older and having a higher prevalence of comorbidities and STS PROM, they had fewer perioperative complications and shorter hospital stay; however, patient-to-prosthesis mismatch was more common after TAVR-in-valve (44% vs SAVR 12%, P < .001).

In Global News: Long-Term Fontan Circulation, a Shock Team, and the TMVR Learning Curve

Patient Care and General Interest

The American Heart Association published a statement advocating for a holistic care approach for patients with Fontan circulation, noting that these patients are living longer and their unique long-term care needs are being better understood.

Abbott Receives U.S. Approval of Next-Generation MitraClip®

Abbott announced that its fourth-generation MitraClip device, MitraClip G4, was approved by the US Food and Drug Administration on July 15, 2019, to treat mitral regurgitation (MR) in a wider population of patients.  The MitraClip G4 include new clip sizes and an enhanced leaflet grasping feature

Pages

Subscribe to RSS - Transcatheter